HK1026579A1 - Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms - Google Patents

Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Info

Publication number
HK1026579A1
HK1026579A1 HK00104319A HK00104319A HK1026579A1 HK 1026579 A1 HK1026579 A1 HK 1026579A1 HK 00104319 A HK00104319 A HK 00104319A HK 00104319 A HK00104319 A HK 00104319A HK 1026579 A1 HK1026579 A1 HK 1026579A1
Authority
HK
Hong Kong
Prior art keywords
tumor suppressor
treatment
neoplasms
chemotherapy
gene therapy
Prior art date
Application number
HK00104319A
Other languages
English (en)
Inventor
Loretta Nielsen
Jo Ann Horowitz
Daniel C Maneval
G William Demers
Mary Ellen Rybak
Gene Resnick
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of HK1026579A1 publication Critical patent/HK1026579A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
HK00104319A 1997-02-18 2000-07-12 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms HK1026579A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US80175597A 1997-02-18 1997-02-18
US80128597A 1997-02-18 1997-02-18
US80168197A 1997-02-18 1997-02-18
US3806597P 1997-02-18 1997-02-18
US80176597A 1997-02-18 1997-02-18
US4783497P 1997-05-28 1997-05-28
PCT/US1998/003514 WO1998035554A2 (en) 1997-02-18 1998-02-17 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Publications (1)

Publication Number Publication Date
HK1026579A1 true HK1026579A1 (en) 2000-12-22

Family

ID=27556335

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104319A HK1026579A1 (en) 1997-02-18 2000-07-12 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Country Status (19)

Country Link
EP (1) EP0969720B1 (ko)
JP (1) JP2001511815A (ko)
KR (2) KR100620939B1 (ko)
CN (1) CN1248731C (ko)
AT (1) ATE361668T1 (ko)
AU (1) AU737621B2 (ko)
BR (1) BR9807418A (ko)
CA (1) CA2282683A1 (ko)
CZ (1) CZ298488B6 (ko)
DE (1) DE69837754T2 (ko)
ES (1) ES2287974T3 (ko)
HK (1) HK1026579A1 (ko)
HU (1) HUP0004326A3 (ko)
IL (2) IL131447A0 (ko)
NO (1) NO993943L (ko)
NZ (1) NZ337283A (ko)
PL (1) PL193767B1 (ko)
SK (1) SK285969B6 (ko)
WO (1) WO1998035554A2 (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
KR19990029028A (ko) 1995-07-17 1999-04-15 파라비 레이 p16 발현 작제물 및 암 치료에서의 이의 용도
US7163925B1 (en) 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
BR9713368A (pt) 1996-11-20 2001-09-18 Introgen Therapeutics Inc Processo melhorado para a produção e a purificação de vetores adenovirais
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
AR017440A1 (es) * 1997-12-22 2001-09-05 Schering Corp Uso de un inhibidor de fpt y de un agente antineoplasico en la preparacion de un medicamento para terapia de combinacion
US6096757A (en) 1998-12-21 2000-08-01 Schering Corporation Method for treating proliferative diseases
EP1082419A2 (en) * 1998-04-22 2001-03-14 Inex Pharmaceuticals Corp. Combination therapy using nucleic acids and conventional drugs
US6689600B1 (en) 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
AU3735100A (en) * 1999-03-19 2000-10-09 Schering Corporation Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US6911200B2 (en) 2000-03-24 2005-06-28 Cell Genesys, Inc. Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
US7048920B2 (en) 2000-03-24 2006-05-23 Cell Genesys, Inc. Recombinant oncolytic adenovirus for human melanoma
EP1354196B1 (en) * 2000-11-27 2010-09-15 Minerva Biotechnologies Corporation Diagnostics, drug screening and treatment for cancer
EP1340498A1 (en) * 2002-03-01 2003-09-03 Schering Aktiengesellschaft Use of epothilones in the treatment of brain diseases associated with proliferative processes
US7364727B2 (en) 2002-07-22 2008-04-29 Cell Genesys, Inc. Metastatic colon cancer specific promoter and uses thereof
US8034790B2 (en) 2003-12-01 2011-10-11 Introgen Therapeutics Use of MDA-7 to inhibit pathogenic infectious organisms
JPWO2005061007A1 (ja) * 2003-12-24 2007-07-12 学校法人 聖マリアンナ医科大学 癌の抑制方法
KR100809890B1 (ko) * 2003-12-24 2008-03-06 가부시키가이샤 로코모젠 암 억제 방법
CA2586107A1 (en) 2004-11-03 2006-05-18 Introgen Therapeutics Inc. A novel method for the production and purification of adenoviral vectors
US11746159B2 (en) 2015-02-10 2023-09-05 Minerva Biotechnologies Corporation Humanized anti-MUC1* antibodies
CN108030931A (zh) * 2017-03-07 2018-05-15 大连民族大学 一种药物脂质体/p53基因复合物的应用
CN109200295A (zh) * 2018-10-08 2019-01-15 蚌埠医学院 一种用于治疗卵巢癌的药物组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
HUT76057A (en) * 1993-10-15 1997-06-30 Schering Corp Tricyclic sulfonamide compounds, pharmaceutical compositions containing them, which are useful for inhibition of g-protein function and for treatment of proliferative diseases and process for producing them
ATE309238T1 (de) * 1995-12-22 2005-11-15 Schering Corp Zur hemming der g-protein-funktion und zur behandlung proliferativer krankheiten geeignete tricyclische amide

Also Published As

Publication number Publication date
IL195605A0 (en) 2011-08-01
KR100620939B1 (ko) 2006-09-06
PL335334A1 (en) 2000-04-25
NO993943L (no) 1999-10-15
SK112299A3 (en) 2000-12-11
ATE361668T1 (de) 2007-06-15
WO1998035554A3 (en) 1998-11-26
EP0969720B1 (en) 2007-05-09
AU6438098A (en) 1998-09-08
EP0969720A4 (en) 2004-05-12
BR9807418A (pt) 2002-01-22
IL131447A0 (en) 2001-01-28
CN1252689A (zh) 2000-05-10
EP0969720A2 (en) 2000-01-12
ES2287974T3 (es) 2007-12-16
KR20050113287A (ko) 2005-12-01
NO993943D0 (no) 1999-08-17
SK285969B6 (sk) 2007-12-06
NZ337283A (en) 2001-02-23
AU737621B2 (en) 2001-08-23
HUP0004326A2 (hu) 2001-02-28
KR100688409B1 (ko) 2007-03-02
PL193767B1 (pl) 2007-03-30
WO1998035554A2 (en) 1998-08-20
KR20000071185A (ko) 2000-11-25
JP2001511815A (ja) 2001-08-14
CZ298488B6 (cs) 2007-10-17
HUP0004326A3 (en) 2003-07-28
DE69837754T2 (de) 2008-02-07
CA2282683A1 (en) 1998-08-20
DE69837754D1 (de) 2007-06-21
CZ293399A3 (cs) 2000-03-15
CN1248731C (zh) 2006-04-05

Similar Documents

Publication Publication Date Title
IL195605A0 (en) Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
EP1004022A4 (en) METHODS AND COMPOSITIONS FOR OVERCOMING RESISTANCE TO BIOLOGICAL THERAPY AND CHEMOTHERAPY
HK1030624A1 (en) Enzyme catalyzed therapeutic agents
IL144559A0 (en) Antibodies for cancer therapy and diagnosis
TR199902053T2 (xx) Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
MX9706109A (es) Moleculas de adn, preparacion y utilizacion en terapia genica.
AU7013401A (en) Methods for enhancing antibody-induced cell lysis and treating cancer
MX9801264A (es) Control de la expresion del gen de cd44 para uso terapeutico.
MY138257A (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
IL128872A0 (en) TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods
WO2003008578A3 (en) Reagents and methods for identifying gene targets for treating cancer
EP1011685A4 (en) METHOD OF TREATING CANCER USING ALKYLGLYCEROLS IN ASSOCIATION WITH CHEMOTHERAPY
NZ503401A (en) Use of interferon-beta (IFN-B) genes for the treatment of cancer
EP0234122A3 (en) Tumor therapy with biologically active anti-tumor antibodies
GB9816583D0 (en) Nucleic acid carrier
HUP9900011A2 (hu) A GAX protein alkalmazása rák kezelésére
EP0950062A4 (en) PROTEIN MARKER FOR OESOPHAGUS CANCER
EP1579863A3 (en) Combination therapy with anti-gastrin G17 antibodies for the treatment of tumors
BR0012301A (pt) Inibidores de crescimento de células epiteliais
WO2000056351A3 (en) Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms
CO5080825A1 (es) Sistema de terapia con genes suicidas para el tratamiento de tumores cerebrales
WO2001034634A8 (en) Tumor suppressor molecules and methods of use
UA25582C2 (uk) Засіб для лікування гематоцитопенічних реакцій теплокровних організмів

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120217